Feature

Coronasomnia: Pervasive sleeplessness, self-medicating raise concerns of sleep experts


 

What to do?

All three sleep experts contacted for this article agreed that for patients with insomnia, mitigating stress through relaxation techniques or cognitive behavioral therapy is more beneficial than medication.

“Medications, even over-the-counter medications, all have side effects, and if one is taking a medication that has stimulants in place, such as pseudoephedrine in antihistamine combinations, that can potentially contribute to or exacerbate any underlying sleep disorders,” Dr. Ramar said.

Dr. Kendzerska recommended reserving medications such as melatonin, a chronobiotic therapy, for patients with sleep disorders related to circadian rhythm problems, including a sleep phase delay. Supplemental, short-term treatment with hypnotic agents such as zolpidem (Ambien), eszopiclone (Lunesta), or zaleplon (Sonata) should be used only as a last resort, she said.

Sleep medicine specialists recommend good sleep hygiene as the best means of obtaining restful sleep, including regular bed and wake times, limited exposure to stressful news (including COVID-19 stories), reduced consumption of alcohol and stimulants such as coffee or caffeine drinks, avoiding use of electronic devices in bed or near bedtime, and healthy lifestyle, including diet and exercise.

They also frown on self-medication with over-the-counter aids, because these products may not be addressing the underlying issue, as noted before.

“It is also foreseeable that there may be an increase in individuals who may require professional guidance to taper off from sleeping medications started or increased during the pandemic. While some of these sleep problems may be transient, it should be a high priority to ensure they do not evolve into chronic sleep disorders,” Dr. Kendzerska and colleagues wrote.

Research avenues

If there’s anything that causes specialists to lose sleep, it’s the lack of data or evidence to guide clinical care and research. Dr. Gozal emphasized that little is still known about the potential central nervous system effects of COVID-19, and said that should be an important focus for research into the still novel coronavirus.

“What happens post COVID and how might that affect subsequent recovery is a great question, and I don’t think we have good data there,” Dr. Ramar said. “What we do know is that patients develop the symptoms of fatigue, disrupted sleep, even ongoing fever, and unfortunately, this may persist for a long period of time even among patients who have otherwise recovered from COVID-19. We know that leaving that untreated from a sleep disorder perspective can exacerbate their daytime symptoms, and that’s where I would strongly recommend that they seek help with a sleep provider or if there are symptoms other than insomnia at least with a primary care provider.”

Pages

Recommended Reading

COVID-19 symptoms persist months after acute infection
Journal of Clinical Outcomes Management
Pressure builds on CDC to prioritize both diabetes types for vaccine
Journal of Clinical Outcomes Management
Long-haul COVID-19 cases rise as stigma of chronic fatigue taunts
Journal of Clinical Outcomes Management
Moderna needs more kids for COVID vaccine trials
Journal of Clinical Outcomes Management
COVID-19 in children: Latest weekly increase is largest yet
Journal of Clinical Outcomes Management
Further warning on SGLT2 inhibitor use and DKA risk in COVID-19
Journal of Clinical Outcomes Management
Women physicians and the pandemic: A snapshot
Journal of Clinical Outcomes Management
ACEIs, ARBs safe to continue in COVID-19: Trial published
Journal of Clinical Outcomes Management
Biggest challenges practices faced from COVID last year: MGMA
Journal of Clinical Outcomes Management
Controversy flares over ivermectin for COVID-19
Journal of Clinical Outcomes Management